Delivery Order SPE2DR25D1053-SPE2DR26FV064
- Not listed
- The Defense Logistics Agency awarded a $4,066.16 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with an ultimate completion date of January 12, 2026. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $6,099.24 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Nemluvio 30 mg pens. The contract represents a firm fixed-price delivery order with an ultimate completion date of December 30, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured without set-aside designation, demonstrating AmerisourceBergen's capability to meet...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for $4,066.16 to supply Nemluvio 30 mg pens. The contract, awarded on December 1, 2025, with an ultimate completion date of December 22, 2025, utilizes a firm fixed price structure with no set-aside designation. This delivery order represents a competitively awarded transaction under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $7,471 delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for supply of Nemluvio 30 mg pens. The contract is a firm fixed-price, competitive award with no set-aside designation and is scheduled for completion by November 28, 2025. AmerisourceBergen will perform this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $2,033.08 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with an ultimate completion date of December 24, 2025. This competitive, non-set-aside contract utilizes firm fixed-price pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single procurement action under AmerisourceBergen's existing relationship with the federal government's medical...
- The Defense Logistics Agency awarded a delivery order valued at $4,066.16 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens on December 15, 2025, with an ultimate completion date of January 7, 2026. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,066.16 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens on December 2, 2025, with an ultimate completion date of December 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a $2,033.08 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Nemluvio 30 mg pens. This is a firm fixed-price, competitively awarded contract with a completion date of December 22, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award is issued under a larger Indefinite Delivery Contract vehicle. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens valued at $1,929.20 under a firm fixed price contract. The award, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive delivery order executed without set-aside provisions. AmerisourceBergen will perform this pharmaceutical supply delivery from its Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Nemluvio 30 mg pens, with a ceiling value of $4,066.16. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract is scheduled for ultimate completion on January 7, 2026, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV064Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,066.16 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens under a firm fixed price contract. The award was made on December 29, 2025, with an ultimate completion date of January 21, 2026. This is a competitively awarded, non-set-aside contract, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military and veteran healthcare systems. The contract demonstrates the company's established capability to fulfill federal pharmaceutical procurement requirements and serves customers including the Defense Health Agency and U.S. Coast Guard through flexible contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 12/28/25 |